(CercleFinance.com) – Equasens posted 2022 revenue growth of 10.9% to 214.1 million euros. On a like-for-like basis (including Prokov Editions over the last quarter), it rose by 8.8% to 210.1 million.
The software solutions company for health thus believes that it has ‘confirmed the efficiency of its growth strategy (organic and external)’ and that ‘the Ségur referencing of its software has consecrated its know-how and technological expertise’.
Equasens anticipates results for 2022 ‘in line with previous years’ and for 2023, ‘maintains its ambitions for expansion in Europe and development in other areas of health’.